Phase 3 Study Findings Demonstrate Treatment With Baricitinib Results In Significant Improvements For Patients...
Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced that detailed results...
Proteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for...
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases...
ASLAN Pharmaceuticals named Asian Biotech of the year
ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents...
FDA Grants Genentech’s Cancer Immunotherapy Atezolizumab Priority Review for Advanced Bladder Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...
Quintiles and the American College of Surgeons Announce Agreement to Develop Clinical Registry of...
Quintiles and the American College of Surgeons (ACS) today announced a six-year strategic services agreement...
Amgen Wins Patent Case On Repatha
Amgen announced that a Delaware jury delivered a verdict in Amgen's favor in a trial...
Biocon Inks Co-Development & Commercialization Agreement with Lab PiSA for rh- Insulin in USA
Biocon Ltd. (BSE code: 532523, NSE: BIOCON) Asia's premier biopharmaceuticals company, announced today that its...
Scripps Florida Scientists Win $1.4 Million Grant to Develop New Ways to Block Breast...
AbbVie and Boehringer Ingelheim announced a global collaboration to develop and commercialize BI 655066, an...
ModiQuest Research and Sobi™ to Continue their Collaboration on Antibody Generation
The Dutch antibody services company, today announced that it will continue its collaboration with Sobi™...
ANI Pharmaceuticals and Dexcel Announce FDA Approval of Donepezil Hydrochloride 23mg Tablets
ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that its collaboration partner Dexcel Pharma Technologies...
